Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
Pentraxin 3 (PTX3) is an essential component of the humoral arm of innate immunity and belongs, together with the C-reactive protein (CRP) and other acute phase proteins, to the pentraxins' superfamily: soluble, multifunctional, pattern recognition proteins. Pentraxins share a common C-terminal...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2013/725102 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850232824382095360 |
|---|---|
| author | Fabrizia Bonacina Andrea Baragetti Alberico Luigi Catapano Giuseppe Danilo Norata |
| author_facet | Fabrizia Bonacina Andrea Baragetti Alberico Luigi Catapano Giuseppe Danilo Norata |
| author_sort | Fabrizia Bonacina |
| collection | DOAJ |
| description | Pentraxin 3 (PTX3) is an essential component of the humoral arm of innate immunity and belongs, together with the C-reactive protein (CRP) and other acute phase proteins, to the pentraxins' superfamily: soluble, multifunctional, pattern recognition proteins. Pentraxins share a common C-terminal pentraxin domain, which in the case of PTX3 is coupled to an unrelated long N-terminal domain. PTX3 in humans, like CRP, correlates with surrogate markers of atherosclerosis and is independently associated with the risk of developing vascular events. Studies addressing the potential physiopathological role of CRP in the cardiovascular system were so far inconclusive and have been limited by the fact that the sequence and regulation have not been conserved during evolution between mouse and man. On the contrary, the conservation of sequence, gene organization, and regulation of PTX3 supports the translation of animal model findings in humans. While PTX3 deficiency is associated with increased inflammation, cardiac damage, and atherosclerosis, the overexpression limits carotid restenosis after angioplasty. These observations point to a cardiovascular protective effect of PTX3 potentially associated with the ability of tuning inflammation and favor the hypothesis that the increased levels of PTX3 in subjects with cardiovascular diseases may reflect a protective physiological mechanism, which correlates with the immunoinflammatory response observed in several cardiovascular disorders. |
| format | Article |
| id | doaj-art-01eeff3f47314c5c953975699e3b8550 |
| institution | OA Journals |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-01eeff3f47314c5c953975699e3b85502025-08-20T02:03:05ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/725102725102Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular DiseasesFabrizia Bonacina0Andrea Baragetti1Alberico Luigi Catapano2Giuseppe Danilo Norata3Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, 20133 Milan, ItalyDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, 20133 Milan, ItalyDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, 20133 Milan, ItalyDepartment of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, 20133 Milan, ItalyPentraxin 3 (PTX3) is an essential component of the humoral arm of innate immunity and belongs, together with the C-reactive protein (CRP) and other acute phase proteins, to the pentraxins' superfamily: soluble, multifunctional, pattern recognition proteins. Pentraxins share a common C-terminal pentraxin domain, which in the case of PTX3 is coupled to an unrelated long N-terminal domain. PTX3 in humans, like CRP, correlates with surrogate markers of atherosclerosis and is independently associated with the risk of developing vascular events. Studies addressing the potential physiopathological role of CRP in the cardiovascular system were so far inconclusive and have been limited by the fact that the sequence and regulation have not been conserved during evolution between mouse and man. On the contrary, the conservation of sequence, gene organization, and regulation of PTX3 supports the translation of animal model findings in humans. While PTX3 deficiency is associated with increased inflammation, cardiac damage, and atherosclerosis, the overexpression limits carotid restenosis after angioplasty. These observations point to a cardiovascular protective effect of PTX3 potentially associated with the ability of tuning inflammation and favor the hypothesis that the increased levels of PTX3 in subjects with cardiovascular diseases may reflect a protective physiological mechanism, which correlates with the immunoinflammatory response observed in several cardiovascular disorders.http://dx.doi.org/10.1155/2013/725102 |
| spellingShingle | Fabrizia Bonacina Andrea Baragetti Alberico Luigi Catapano Giuseppe Danilo Norata Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases Mediators of Inflammation |
| title | Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases |
| title_full | Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases |
| title_fullStr | Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases |
| title_full_unstemmed | Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases |
| title_short | Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases |
| title_sort | long pentraxin 3 experimental and clinical relevance in cardiovascular diseases |
| url | http://dx.doi.org/10.1155/2013/725102 |
| work_keys_str_mv | AT fabriziabonacina longpentraxin3experimentalandclinicalrelevanceincardiovasculardiseases AT andreabaragetti longpentraxin3experimentalandclinicalrelevanceincardiovasculardiseases AT albericoluigicatapano longpentraxin3experimentalandclinicalrelevanceincardiovasculardiseases AT giuseppedanilonorata longpentraxin3experimentalandclinicalrelevanceincardiovasculardiseases |